Innocoll to Report Fourth Quarter 2015 Financial Results and Host Webcast and Conference Call on March 17, 2016
11 mars 2016 16h30 HE
|
Innocoll Holdings plc
ATHLONE, Ireland, March 11, 2016 (GLOBE NEWSWIRE) -- Innocoll AG (Nasdaq:INNL) (the "Company"), a global, commercial stage, specialty pharmaceutical company with late stage development programs...
Innocoll AG Appoints Charles Katzer as Head of Manufacturing and Technical Operations
17 déc. 2015 08h30 HE
|
Innocoll Holdings plc
ATHLONE, Ireland, Dec. 17, 2015 (GLOBE NEWSWIRE) -- Innocoll AG (NASDAQ:INNL) announced that Charles Katzer has been appointed head of Manufacturing and Technical Operations effective immediately....
Innocoll AG Announces Plan to Move Corporate Domicile to Ireland
09 déc. 2015 16h30 HE
|
Innocoll Holdings plc
ATHLONE, Ireland, Dec. 09, 2015 (GLOBE NEWSWIRE) -- Innocoll AG (NASDAQ:INNL) today announced that its supervisory board has unanimously approved a plan to move the company’s legal domicile from...
Innocoll AG Announces Third Quarter 2015 Financial and Operating Results and Corporate Update
11 nov. 2015 08h00 HE
|
Innocoll Holdings plc
ATHLONE, Ireland, Nov. 11, 2015 (GLOBE NEWSWIRE) -- Innocoll AG (Nasdaq:INNL), a global, commercial-stage, specialty pharmaceutical company that develops, manufactures and supplies a range of...
Innocoll to Report Third Quarter 2015 Financial Results and Host Webcast and Conference Call on November 11, 2015
04 nov. 2015 16h05 HE
|
Innocoll Holdings plc
ATHLONE, Ireland, Nov. 04, 2015 (GLOBE NEWSWIRE) -- Innocoll AG (Nasdaq:INNL) (the "Company"), a global, commercial-stage, specialty pharmaceutical company that develops and manufactures a range of...
Innocoll AG Announces First Patient Dosed in the XaraColl MATRIX-2 Phase 3 Study for the Treatment of Postoperative Pain
16 sept. 2015 08h00 HE
|
Innocoll Holdings plc
ATHLONE, Ireland, Sept. 16, 2015 (GLOBE NEWSWIRE) -- Innocoll AG (NASDAQ:INNL), a global, commercial-stage, specialty pharmaceutical company that develops, manufactures and supplies a range of...
Innocoll AG Announces Departure of Chief Medical Officer
14 sept. 2015 08h00 HE
|
Innocoll Holdings plc
ATHLONE, Ireland, Sept. 14, 2015 (GLOBE NEWSWIRE) -- Innocoll AG (NASDAQ:INNL) announced that James P. Tursi, M.D., will depart Innocoll to pursue another opportunity. Dr. Tursi will remain with...
Innocoll AG Announces First Patient Dosed in the XaraColl MATRIX-1 Phase 3 Study for the Treatment of Postoperative Pain
02 sept. 2015 08h00 HE
|
Innocoll Holdings plc
ATHLONE, Ireland, Sept. 2, 2015 (GLOBE NEWSWIRE) -- Innocoll AG (NASDAQ:INNL), a global, commercial-stage, specialty pharmaceutical company that develops, manufactures and supplies a range of...
Innocoll AG Announces Second Quarter 2015 Financial and Operating Results and Updates Late-Stage Product Portfolio Progress
14 août 2015 08h00 HE
|
Innocoll Holdings plc
ATHLONE, Ireland, Aug. 14, 2015 (GLOBE NEWSWIRE) -- Innocoll AG (Nasdaq:INNL), a global, commercial-stage, specialty pharmaceutical company that develops, manufactures and supplies a range of...
Innocoll AG Appoints Rich Fante as Chief Commercial Officer and Head of Business Development
13 août 2015 08h00 HE
|
Innocoll Holdings plc
ATHLONE, Ireland, Aug. 13, 2015 (GLOBE NEWSWIRE) -- Innocoll AG (NASDAQ:INNL) announced that Rich Fante has been appointed Chief Commercial Officer and Head of Business Development effective August...